1. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions 
Sezai Çelik, MD, Chiara Lestuzzi, MD, Eugenio Cervesato, PhD, Didier Dequanter, MD, Patrizia Piotti, MD, Marzia De Biasio, MD, Massimo Imazio, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 148, Issue 5, Pages (November 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Kaplan-Meier survival curve. In 1 case follow-up was truncated to 3290 days; this is the max value plotted. CT, Chemotherapy; N.S., not significant.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions